Leerink Partners Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Target of $49
Portfolio Pulse from Benzinga Newsdesk
Leerink Partners has initiated coverage on Tectonic Therapeutic (NASDAQ:TECX) with an Outperform rating and a price target of $49.
July 24, 2024 | 3:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Leerink Partners has initiated coverage on Tectonic Therapeutic with an Outperform rating and a price target of $49.
The initiation of coverage with an Outperform rating and a specific price target of $49 by a reputable analyst is likely to positively impact the stock price of Tectonic Therapeutic in the short term. Investors often react favorably to such endorsements.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100